dopamine quinone has been researched along with metallothionein in 2 studies
| Studies (dopamine quinone) | Trials (dopamine quinone) | Recent Studies (post-2010) (dopamine quinone) | Studies (metallothionein) | Trials (metallothionein) | Recent Studies (post-2010) (metallothionein) |
|---|---|---|---|---|---|
| 61 | 0 | 29 | 9,390 | 41 | 2,223 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asanuma, M; Hozumi, H; Miyazaki, I; Miyoshi, K; Sogawa, N | 1 |
| Asanuma, M; Kikkawa, Y; Kita, T; Miyazaki, I; Miyoshi, K; Murakami, S; Sogawa, N; Takeshima, M | 1 |
2 other study(ies) available for dopamine quinone and metallothionein
| Article | Year |
|---|---|
Protective effects of metallothionein against dopamine quinone-induced dopaminergic neurotoxicity.
Topics: Animals; Cell Line; Cytoprotection; Dopamine; Dopamine Agents; Levodopa; Metallothionein; Mice; Mice, Knockout; Oxidopamine; Parkinson Disease, Secondary; RNA, Messenger; Zinc | 2007 |
Astrocyte-derived metallothionein protects dopaminergic neurons from dopamine quinone toxicity.
Topics: Animals; Astrocytes; Cells, Cultured; Coculture Techniques; Dopamine; Free Radical Scavengers; Metallothionein; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley | 2011 |